F12 Produits
(Coagulation Factor XII (F12))
Catégories
This gene encodes coagulation factor XII which circulates in blood as a zymogen. This single chain zymogen is converted to a two-chain serine protease with an heavy chain (alpha-factor XIIa) and a light chain. The heavy chain contains two fibronectin-type domains, two epidermal growth factor (EGF)-like domains, a kringle domain and a proline-rich domain, whereas the light chain contains only a catalytic domain. On activation, further cleavages takes place in the heavy chain, resulting in the production of beta-factor XIIa light chain and the alpha-factor XIIa light chain becomes beta-factor XIIa heavy chain. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then to beta-factor XIIa. The active factor XIIa participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. It activates coagulation factors VII and XI. Defects in this gene do not cause any clinical symptoms and the sole effect is that whole-blood clotting time is prolonged. [provided by RefSeq, Jul 2008].
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories F12 en vedette
F12 Anticorps
High quality antibodies with extensive validation data.
F12 Kits ELISA
Reliable ELISA kits for a wide range of species.
F12 Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
F12 recommandé Anticorps
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Application
WB, IHC, IP, ICC
Validations
- (3)
N° du produit
ABIN7432373
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Mouse
Application
WB, IHC, IP, ICC
Validations
- (3)
N° du produit
ABIN7432376
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, ELISA, PLA
Validations
- (3)
N° du produit
ABIN560829
Quantité
100 μg
Fiche technique
Fiche technique
F12 recommandé Kits ELISA
Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
- (1)
N° du produit
ABIN6954882
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN6965907
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Rat
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN6965909
Quantité
96 tests
Fiche technique
Fiche technique
F12 recommandé Protéines
Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Source
Wheat germ
Validations
- (1)
N° du produit
ABIN1353303
Quantité
10 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
Wheat germ
Validations
- (1)
N° du produit
ABIN1353299
Quantité
10 μg
Fiche technique
Fiche technique
Reactivity
Mouse
Source
Escherichia coli (E. coli)
Validations
N° du produit
ABIN7391612
Quantité
100 μg
Fiche technique
Fiche technique
Dernières publications sur nos produits F12
: "Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection." dans: Nature communications, Vol. 7, pp. 12616, (2018) (PubMed).: "Ex vivo simulation of cardiopulmonary bypass with human blood for hemocompatibility testing." dans: Perfusion, Vol. 31, Issue 5, pp. 376-83, (2016) (PubMed).
: "β-Eliminative depolymerization of the fucosylated chondroitin sulfate and anticoagulant activities of resulting fragments." dans: Carbohydrate polymers, Vol. 127, pp. 427-37, (2015) (PubMed).
: "A Synthetic Factor XIIa Inhibitor Blocks Selectively Intrinsic Coagulation Initiation." dans: ACS chemical biology, Vol. 10, Issue 8, pp. 1861-70, (2015) (PubMed).
: "Proteomic profiles in acute respiratory distress syndrome differentiates survivors from non-survivors." dans: PLoS ONE, Vol. 9, Issue 10, pp. e109713, (2014) (PubMed).
: "Identification of target-binding peptide motifs by high-throughput sequencing of phage-selected peptides." dans: Nucleic acids research, Vol. 42, Issue 22, pp. e169, (2014) (PubMed).
: "Variance decomposition of protein profiles from antibody arrays using a longitudinal twin model." dans: Proteome science, Vol. 9, pp. 73, (2011) (PubMed).
: "Molecular mechanisms of thrombus formation in ischemic stroke: novel insights and targets for treatment." dans: Blood, Vol. 112, Issue 9, pp. 3555-62, (2008) (PubMed).
: "Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation." dans: The Journal of clinical investigation, Vol. 118, Issue 9, pp. 3208-18, (2008) (PubMed).
: "The elusive physiologic role of Factor XII." dans: The Journal of clinical investigation, Vol. 118, Issue 9, pp. 3006-9, (2008) (PubMed).
Synonymes et noms alternatifs relatifs à F12
coagulation factor XII (F12), coagulation factor XII (Hageman factor) (F12), FXII, HAE3, HAEX, HAFProtein level used designations for F12
- Hageman factor
- beta-factor XIIa part 1
- beta-factor XIIa part 2
- coagulation factor XII
- coagulation factor XIIa heavy chain
- coagulation factor XIIa light chain
- factor XII
- hageman factor
- HAF
Avez-vous cherché autre chose?
Vous êtes ici:
